Valuation: Pathkey.AI Ltd

Market Cap 81.89M 58.06M 50.14M 47.12M 42.85M 80.57M 5.55B 552M 216M 2.78B 218M 213M 9.24B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 81.87M 58.04M 50.13M 47.1M 42.84M 80.54M 5.55B 552M 216M 2.78B 218M 213M 9.24B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day+2.63%
1 week+5.41%
Current month+34.48%
3 months-9.30%
6 months+69.57%
Current year+143.75%
1 week 0.04
Extreme 0.035
0.04
1 month 0.03
Extreme 0.027
0.04
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
+2.63%+5.41%+69.57%-18.75% 33.48M
-3.52%+5.76%-13.14%+26.98% 39.6B
-1.68%-0.42%-44.65%+148.11% 13.25B
-0.78%+3.62%-20.23%+71.85% 5.74B
+35.70%+46.01%+35.00% - 3.66B
+4.06%+8.99% - - 2.01B
-0.90%+1.33%+17.70%-41.20% 1.7B
+1.59%-7.61%-40.42% - 967M
+1.97%+0.86%+38.78%+130.05% 924M
-0.82%+0.28%-32.47%-45.83% 836M
Average +3.83%+8.64%+1.13%+38.74% 6.87B
Weighted average by Cap. -0.38%+6.80%-16.45%+55.64%

Financials

2024 2025
Net sales 398K 282K 243K 229K 208K 391K 26.96M 2.68M 1.05M 13.5M 1.06M 1.04M 44.86M 322K 228K 197K 185K 168K 317K 21.83M 2.17M 849K 10.93M 857K 838K 36.32M
Net income -3.13M -2.22M -1.92M -1.8M -1.64M -3.08M -212M -21.1M -8.25M -106M -8.33M -8.15M -353M -1.45M -1.03M -886K -833K -758K -1.42M -98.14M -9.76M -3.82M -49.15M -3.85M -3.77M -163M
Net Debt -375K -266K -229K -216K -196K -369K -25.4M -2.53M -988K -12.72M -997K -976K -42.26M -25.17K -17.84K -15.41K -14.48K -13.17K -24.76K -1.71M -170K -66.34K -854K -66.98K -65.53K -2.84M
Logo Pathkey.AI Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
26-08-17 A$0.0390 +2.63% 9,617,378
26-08-14 A$0.0380 +5.56% 2,497,219
26-08-13 A$0.0360 -2.70% 6,533,852
26-08-12 A$0.0370 +19.35% 31,104,949